These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12634651)

  • 21. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO; Stamilio DM; Nelson DB; Sehdev HM; Macones GA
    Obstet Gynecol; 2005 Sep; 106(3):562-8. PubMed ID: 16135588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy.
    Spencer K
    Prenat Diagn; 2002 Dec; 22(13):1229-32. PubMed ID: 12478639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
    Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
    Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening.
    Hackshaw A; Wald N
    Prenat Diagn; 2002 Nov; 22(11):1051-3. PubMed ID: 12424775
    [No Abstract]   [Full Text] [Related]  

  • 27. [Down syndrome screening in France: the worst consensus].
    Rozenberg P; Bussières L; Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):95-103. PubMed ID: 17289296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of prenatal follow-up strategies for trisomy 21 affected pregnancies in France].
    Dupont JM; Simon-Bouy B; Zebina A; Pessione F; Royère D; Doco-Fenzy M;
    Gynecol Obstet Fertil Senol; 2017 Mar; 45(3):152-157. PubMed ID: 28258854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
    Nicolaides KH
    Am J Obstet Gynecol; 2004 Jul; 191(1):45-67. PubMed ID: 15295343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.
    Maxwell S; James I; Dickinson JE; O'Leary P
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland.
    Peuhkurinen S; Laitinen P; Honkasalo T; Ryynanen M; Marttala J
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):769-74. PubMed ID: 23369035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies.
    Herman A; Weinraub Z; Dreazen E; Arieli S; Rozansky S; Bukovsky I; Maymon R
    Prenat Diagn; 2000 Oct; 20(10):781-4. PubMed ID: 11038452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuchal translucency measurement and second-trimester biochemical screening for Down's syndrome.
    Frohlich EP
    Ultrasound Obstet Gynecol; 1997 Sep; 10(3):221-2. PubMed ID: 9339533
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used?
    Gekas J; Durand A; Bujold E; Vallée M; Forest JC; Rousseau F; Reinharz D
    Am J Obstet Gynecol; 2011 Feb; 204(2):175.e1-8. PubMed ID: 21074138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.